Dosage & Administration Drug label Financial assistance

Savaysa

(edoxaban)

Savaysa 15 MG Oral TabletSavaysa 30 MG Oral Tablet

View 1 more

Dosage & administration

* Treatment of NVAF:
Assess CrCL before initiating therapy
The recommended dose is 60 mg once daily in patients with CrCL >50 to ≤ 95 mL/min. Do not use SAVAYSA in patients with CrCL > 95 mL/min
Reduce dose to 30 mg once daily in patients with creatinine clearance 15 to 50 mL/min

* Treatment of DVT and PE:
The recommended dose is 60 mg once daily
Reduce dose to 30 mg once daily for patients with CrCL 15 to 50 mL/min or body weight less than or equal to 60 kg or who use certain P-gp inhibitors

drug label

Savaysa prescribing information

Contact Medical Science Liaison Report Adverse Event

financial assistance

Savaysa financial assistance options

Co-pay savings program

commercial only

OTHEREnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

patient education

Savaysa patient education

Getting started on Savaysa

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

BRAND PAGEAbout Savaysa: Deep Vein Thrombosis (DVT) & Pulmonary Embolism (PE)

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGEAbout Savaysa: Risk Reduction of Stroke and Systemic Embolism (SE) In Nonvalvular Atrial Fibrillation (NVAF)

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Other resources

Learn More

Savaysa FAQs

How is the dosage of Savaysa?Savaysa is available in 3 dosages, including 15 mg Tab, 30 mg Tab and 60 mg Tab

What does Savaysa treat?Savaysa treats Pulmonary Embolism and Venous Thrombosis

What is Savaysa made of?Savaysa contains edoxaban which is a Factor Xa Inhibitor

How Is Savaysa Administered?Savaysa is administered as a Oral Pill

What Are The Savaysa Mechanism Of Action?Savaysa mechanism of action is Factor Xa Inhibitors

FAQ Data Source

Savaysa

Dosage & administration

drug label

Savaysa prescribing information

financial assistance

Savaysa financial assistance options

Co-pay savings program

patient education

Savaysa patient education

Getting started on Savaysa

Patient toolkit

Other resources

people also ask

Savaysa FAQs